Ventripoint Diagnostics will exhibit its AI-driven cardiac imaging technology, VMS+™, at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology in Italy. The event gathers over 1,000 specialists focused on congenital heart disease (CHD), highlighting Ventripoint's role in advancing echocardiography for lifelong CHD patient care. VMS+™ offers MRI-level accuracy in cardiac volume measurement, streamlining clinical workflows and supporting better patient management. Ventripoint aims to integrate VMS+™ more widely into routine practice throughout 2026.
Bitcoin faces pressure even as the U.S. Dollar Index weakens and rate hike bets fade, due to record outflows from spot Bitcoin ETFs totaling $4.0 to $4.5 billion in June. A softer dollar typically supports Bitcoin by improving global purchasing power...
Imugene Ltd announced a second complete response in its Phase 1b azer-cel trial targeting patients with mantle cell lymphoma (MCL) who had failed prior BTKi therapy. The patient showed complete tumor shrinkage by Day 28, earlier than expected, highli...
Revolut will remove Tether's USDT stablecoin from its platform by August 31, 2026, disabling purchases from July 6. This move aligns with regulatory and risk considerations under the EU's new Markets in Crypto-Assets (MiCA) rules, which have led othe...
XRP price has rebounded to around $1.145, showing a 4% gain in 24 hours, after forming a double bottom near $1.05 and $1.0092, which suggests sellers may be losing control. The key level to watch is the $1.28 to $1.29 neckline; a daily close above th...
Revolut, a major European fintech platform, will stop supporting Tether (USDT) stablecoin by August 31, 2026. Users can buy USDT until July 6 and deposit until July 30, but after August 31, remaining USDT balances will convert to fiat currency. This ...
